How many 8-K filings has Tectonic Therapeutic, Inc. filed?

Tectonic Therapeutic, Inc. (TECX) has 17 8-K (Current Event Report) filings on record, spanning Jan 2024 to Oct 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Tectonic Therapeutic, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Tectonic Therapeutic, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Tectonic Therapeutic, Inc. (TECX) — 8-K Filings

All 8-K filings from Tectonic Therapeutic, Inc.. Browse 17 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (17)

Tectonic Therapeutic Files 8-K — Oct 30, 2025 Risk: medium
Tectonic Therapeutic, Inc. filed an 8-K on October 30, 2025, reporting an event on October 29, 2025. The filing indicates a change in the company's status or op
Tectonic Therapeutic Files 8-K — Aug 7, 2025 Risk: medium
On August 7, 2025, Tectonic Therapeutic, Inc. filed an 8-K report. The filing indicates a change in the company's status or operations, as it is a current repor
Tectonic Therapeutic Files 8-K on Security Holder Vote — Jun 6, 2025 Risk: low
Tectonic Therapeutic, Inc. filed an 8-K on June 6, 2025, to report on matters submitted to a vote of its security holders. The filing does not disclose specific
Tectonic Therapeutic Files 8-K — May 19, 2025 Risk: low
Tectonic Therapeutic, Inc. filed an 8-K on May 19, 2025, reporting on events as of May 17, 2025. The filing primarily concerns financial statements and exhibits
Tectonic Therapeutic Files 8-K: Material Agreement & Equity Sales — Feb 3, 2025 Risk: medium
On February 3, 2025, Tectonic Therapeutic, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securiti
Tectonic Therapeutic Files 8-K — Jan 30, 2025 Risk: low
On January 30, 2025, Tectonic Therapeutic, Inc. filed an 8-K report. The filing indicates that the company is a biotechnology firm focused on biological product
Tectonic Therapeutic, Inc. Files 8-K — Jan 13, 2025 Risk: low
On January 13, 2025, Tectonic Therapeutic, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 490 Arsenal W
Tectonic Therapeutic Files 8-K on Financials — Nov 7, 2024 Risk: low
On November 7, 2024, Tectonic Therapeutic, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition,
Tectonic Therapeutic Files 8-K with Financials — Sep 19, 2024 Risk: low
On September 19, 2024, Tectonic Therapeutic, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, and includes a Regulatio
Roivant Sciences to Acquire Tectonic Therapeutic — Jul 30, 2024 Risk: medium
Tectonic Therapeutic, Inc. announced on July 30, 2024, that it has entered into a definitive agreement to be acquired by a subsidiary of Roivant Sciences Ltd. T
Tectonic Therapeutic Appoints New Director — Jul 5, 2024 Risk: low
Tectonic Therapeutic, Inc. announced on June 28, 2024, the election of Dr. Jonathan G. Weaver as a Class III Director, effective immediately. Dr. Weaver, who ha
Tectonic Therapeutic, Inc. Formerly AVROBIO, Inc. — Jun 26, 2024 Risk: low
On June 25, 2024, Tectonic Therapeutic, Inc. filed an 8-K report detailing a corporate name change from AVROBIO, Inc. to Tectonic Therapeutic, Inc., effective J
Vertex Acquires Tectonic Therapeutic for $3.50/share + CVR — Jun 20, 2024 Risk: medium
Tectonic Therapeutic, Inc. announced on June 20, 2024, the completion of its acquisition by a subsidiary of Vertex Pharmaceuticals Incorporated. The transaction
AVROBIO, Inc. Files 8-K Report — Jun 14, 2024 Risk: low
On June 14, 2024, AVROBIO, Inc. filed an 8-K report. The filing indicates that the company is providing an update on its business and financial condition. No sp
AVROBIO, Inc. Files 8-K on Security Holder Vote Matters — Jun 11, 2024 Risk: low
On June 11, 2024, AVROBIO, Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing does not disclose specific
AVROBIO, Inc. Files 8-K Report — Jun 4, 2024 Risk: low
On June 4, 2024, AVROBIO, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific financial transactions or
AVROBIO Signals Major Corporate Changes, Potential Control Shift — Jan 30, 2024
AVROBIO, Inc. filed an 8-K on January 30, 2024, indicating significant corporate changes, including entry into a material definitive agreement, potential change

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX